IgA Nephropathy

>

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.

Latest News

 Jonathan Barratt, MBChB, PhD, Mayer Professor of Renal Medicine, University of Leicester, Leicester, United Kingdom
Felzartamab Slows IgAN Decline in New Phase 2 Data

October 30th 2024

Complete, 24-month data from the IGNAZ study were presented at the ASN Kidney Week 2024 Meeting.

Jonathan Barratt, PhD | Credit: IgA Nephropathy Foundation
ORIGIN OLE Data Solidify Atacicept Disease-Modifying Potential for IgA Nephropathy

October 27th 2024

Sibeprenlimab Meaningfully Reduces uPCR in Adults With IgA Nephropathy
Sibeprenlimab Meaningfully Reduces uPCR in Adults With IgA Nephropathy

October 23rd 2024

HCPLive Nephrology Month in Review: September 2024
Nephrology Month in Review: September 2024

October 7th 2024

Yusuke Suzuki, MD, PhD | Credit: Juntendo University
Gender, IgA Nephropathy Linked to Gross Hematuria After COVID-19 Vaccination

October 3rd 2024

Video Interviews
Podcasts
Square thumbnail for Kidney Compass podcast featuring headshots of hosts and HCPLive logos

More News

© 2024 MJH Life Sciences

All rights reserved.